Series A · Healthtech · London, United Kingdom · 11–50 employees
DnaNudge developed the world's first DNA-based service for personalized nutrition recommendations while shopping, using a wearable device that scans product barcodes and provides real-time genetic compatibility feedback. The company successfully pivoted during COVID-19 to create rapid, lab-free PCR testing technology that delivers results in 90 minutes without laboratory processing. Founded by Imperial College London's Professor Chris Toumazou and Dr. Maria Karvela, the company won the prestigious Royal Academy of Engineering MacRobert Award in 2021 for its breakthrough diagnostic technology. DnaNudge recently signed a multi-million dollar licensing agreement with NantNudge to accelerate handheld AI genomics applications, expanding beyond nutrition into broader healthcare diagnostics including oncology and STD testing.
No open roles listed right now.